Bicycle Therapeutics Ownership & Insider Activity

Bicycle Therapeutics (BCYC) institutional and insider ownership, recent insider transactions and ownership breakdown.

Insiders own 2.8% of shares outstanding. Institutional investors hold 3.6%. Over the past 90 days, insiders made 6 sales worth $63K.

Shares Outstanding

69.811M

Shares Float

38.870M

Insider Shares Owned

1.930M

Insider % Owned

2.8%

Institutional Shares Held

2.547M

Institutional % Held

3.6%

Ownership Breakdown

Net Insider Activity by Month

Purchases (90d)

Sales (90d)

$63K total

Net Activity

Net Selling

Net Value (90d)

-$63K

Bicycle Therapeutics Insider Transactions (Last 6 Months)

Date	Insider	Title	Type	Shares	Price	Value
Oct 2, 2026	Charles Robert Swanton	—	SELL	3.431K	$3.47	$12K
Oct 2, 2026	Michael Skynner	CHIEF SCIENTIFIC OFFICER	SELL	2.445K	$3.49	$9K
Oct 2, 2026	Ferguson Charles Michael Hannay	CHIEF PROD & SUPPLY CHAIN OFF	SELL	1.814K	$3.48	$6K
Oct 2, 2026	Scott Jennifer Perry	CHIEF OPERATING OFFICER	SELL	1.500K	$3.54	$5K
Oct 2, 2026	Kevin Lee	CHIEF EXECUTIVE OFFICER	SELL	7.805K	$3.49	$27K
Oct 2, 2026	Travis Thompson	CHIEF FINANCIAL OFFICER	SELL	972.000	$3.48	$3K
Jul 2, 2026	Scott Jennifer Perry	CHIEF OPERATING OFFICER	SELL	1.412K	$4.29	$6K
Jul 2, 2026	Michael Skynner	CHIEF SCIENTIFIC OFFICER	SELL	2.391K	$4.28	$10K
Jul 2, 2026	Kevin Lee	CHIEF EXECUTIVE OFFICER	SELL	7.642K	$4.28	$33K
Jul 2, 2026	Ferguson Charles Michael Hannay	CHIEF PROD & SUPPLY CHAIN OFF	SELL	1.761K	$4.28	$8K
Jul 2, 2026	Travis Thompson	CHIEF FINANCIAL OFFICER	SELL	923.000	$4.27	$4K